Results 251 to 260 of about 209,966 (285)
Some of the next articles are maybe not open access.

Pulmonary rehabilitation in idiopathic pulmonary fibrosis

Current Opinion in Pulmonary Medicine
Purpose of review This review synthesizes the expanding evidence for pulmonary rehabilitation that has led to its recommended inclusion in the holistic care of people with idiopathic pulmonary fibrosis (IPF), as well as discussing strategies that may maximize and sustain benefits.
Leona M, Dowman, Anne E, Holland
openaire   +2 more sources

Idiopathic pulmonary fibrosis

2010
The synonymous terms idiopathic pulmonary fibrosis (IPF) and cryptogenic fibrosing alveolitis (CFA) refer to a relentlessly progressive fibrotic lung disorder that is the underlying diagnosis in over one-half of patients presenting with typical clinical features of the ‘CFA clinical syndrome’ (see Chapter 18.11.1).
A.U. Wells, A.G. Nicholson, N. Hirani
openaire   +1 more source

Idiopathic Pulmonary Fibrosis

Archives of Internal Medicine, 1981
BETSY Harris, MD, Assistant Resident in Medicine, the Jewish Hospital of St Louis: A 49-year-old woman was admitted to the hospital with a five-day history of short-ness of breath. Two weeks before admission, a cough that produced "some whitish material" developed and an oral temperature of 37°C was recorded.
openaire   +1 more source

Idiopathic Pulmonary Fibrosis

JAAPA
Idiopathic Pulmonary Fibrosis is a groundbreaking book designed to provide pulmonary and internal medicine clinicians and healthcare professionals with a comprehensive understanding of this complex lung disease. Idiopathic pulmonary fibrosis is a chronic and progressive interstitial lung disease characterized by the scarring of lung tissue, leading to ...
  +4 more sources

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

American Journal of Respiratory and Critical Care Medicine, 2015
G. Raghu   +20 more
semanticscholar   +1 more source

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Yearbook of Pulmonary Disease, 2015
Tomohiro Handa, Arata Azuma
semanticscholar   +1 more source

Immune-checkpoint inhibitors: long-term implications of toxicity

Nature Reviews Clinical Oncology, 2022
Douglas B Johnson, Msci   +2 more
exaly  

Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

, 2000
J. King   +11 more
semanticscholar   +1 more source

Idiopathic pulmonary fibrosis

Allergy, 2005
Harari S., Caminati A.
openaire   +2 more sources

Home - About - Disclaimer - Privacy